Post-Market NASDAQ Movers (SQI, CIEN, VELT, BRCD, SREV, XIDE, VRA, CHBT, UTHR, CPRT)

The top after-market NASDAQ Stock Market gainers are: SciQuest, CIENA, Velti, Brocade Communications Systems, and ServiceSource International. The top after-market NASDAQ Stock Market losers are: Exide Technologies, Vera Bradley Designs, China-Biotics, United Therapeutics, and Copart.

Gainers

SciQuest, Inc. (SQI) stock grew 5.42 percent to $16.13 in the after-market trading.

CIENA Corp. (CIEN) stock gained 4.85 percent to $26.72 in the after-market trading.

Velti Plc (VELT) stock gained 4.18 percent to $15.22 in the after-market trading.

Brocade Communications Systems, Inc. (BRCD) stock increased 3.45 percent to $6.90 in the after-market trading. Canaccord Genuity said in a research note that now is the time for Dell (DELL) to make a push into networking in a more concerted fashion, and that Brocade could be a target. Brocade has 70 percent of the fibre channel storage networking market, which has a high return on investment and should be a cash cow for the next five years. The other likely candidate, Juniper Networks (JNPR), gets most of its revenue from carriers, not enterprise, and is therefore not as good a fit, the brokerage said in a note to clients.

ServiceSource International, In (SREV) stock rose 3.20 percent to $19.69 in the after-market trading.

Losers

Exide Technologies (XIDE) stock plunged 12.46 percent to $8.50 in the after-market trading. Adjusted profit for the fourth quarter was $12.9 million or $0.15 per share, down from $37.5 million or $0.49 per share last year. Sales grew to $774.5 million from $714.7 million. Analysts had expected profit of $0.25 per share on revenue of $756 million. Looking ahead, Exide expects first-quarter earnings to slightly shrink on account of higher costs and delayed pricing action.

Vera Bradley Designs, Inc. (VRA) stock fell 11.44 percent to $42.21 in the after-market trading. Profit for the first quarter was $11.2 million or $0.28 per share, down from $16.8 million or $0.47 per share last year. Adjusted profit was $11.2 million or $0.28 per share, up from $10.2 million or $0.25 per share last year. Revenue rose to $101.4 million from $85.0 million. Analysts had expected profit of $0.27 per share on revenue of $100.23 million.

The company expects second quarter earnings of $0.27 to $0.29 per share and revenue of $95 million to $98 million, while Street predicts profit of $0.26 per share on revenue of $94.85 million. For the fiscal 2012, the company expects earnings of $1.27 to $1.30 per share and revenue of $430 million to $435 million, while Street predicts profit of $1.28 per share on revenue of $433.69 million.

China-Biotics, Inc. (CHBT) stock slid 2.87 percent to $6.78 in the after-market trading.

United Therapeutics Corp. (UTHR) stock declined 2.49 percent to $62 in the after-market trading.

Copart, Inc. (CPRT) stock decreased 2.36 percent to $45.10 in the after-market trading. Profit for the third quarter was $50.14 million or $0.71 per share, up from $44.39 million or $0.52 per share in the same quarter of last year. Revenue rose to $236.76 million from $220.35 million. Analysts had expected profit of $0.70 per share on revenue of $241.56 million.